Indicaciones para el uso del misoprostol como tratamiento clínico del aborto.

Abstract

Introduction: Abortion is the expulsion of an embryo or foetus weighing less than 500 g (estimated 20 weeks gestation) or other non-viable gestational products, of any gestational weight or age. Fifteen to twenty percent of confirmed pregnancies are lost in the first trimester or early in the second trimester. There are multiple factors and forms of fetal, maternal or paternal origin that cause alterations and lead to the loss of the gestational product. Objective: to summarise the available data on the effectiveness of the indicative use of misoprostol in the treatment of miscarriage. Methodology: This is a descriptive study, based on a systematic review of the literature, an analysis was made of scientific articles in evidence-based medicine publications of high health impact (Pubmed, Scopus, Cochrane, Springer, NEJM); corresponding to the last 5 years in progress. Conclusion Successful medical treatment will depend on the type of abortion, as well as the dosage of misoprostol, the routes of administration and the time available for evacuation of the products. In suspected previous abortions and caesarean sections, misoprostol should be administered in reduced doses. There is evidence that misoprostol administration is safe and effective, as the route of administration does not influence the success rate, and it can be administered at home by the patient herself, with a good degree of satisfaction and low health care costs, making it a valid alternative to curettage.